Brief: Jeevan Scientific Technology says DCGI approves Hyderabad bioequivalence study centre
Dec 21 (Reuters) - Jeevan Scientific Technology Ltd
JEEV.BO
* Study centre approved by office of Drug Control General,
on 16-Dec-2016 for a period of three years
* Says approval of bioavailability/bioequivalence study
centre at B-17, tie, phase-II, Balanagar, Hyderabad
Source text for Eikon: ID:
Further company coverage: JEEV.BO
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Jeevan Scientific Technology
See all newsBrief: Jeevan Scientific Technology Issue Of Up To 3.5 Million Warrants At 40 Rupees Each
Brief: Jeevan Scientific Technology Completes CDSCO Inspections Of Clinical And Bioanalytical Facilities
Brief: Jeevan Scientific Technology Says USFDA Conducted Inspection At Bioanalytical Facility At Manikonda
Development Agreement With Aditri Pharma Sciences
Brief: WHO Conducted Inspection Of Jeevan Scientific Technology's Bio-Analytical Facility And Clinical Pharmacology Centre, Hyderabad